Treatment of adults with recurrent malignant glioma (Q36198612)

12 August 2017

1 reference

title

Treatment of adults with recurrent malignant glioma (English)

1 reference

12 August 2017

L Burt Nabors

1

1 reference

12 August 2017

John Fiveash

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 July 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

509-514

1 reference

Epidemiology of primary brain tumors: current concepts and review of the literature

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Molecular epidemiology of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Genetics of primary brain tumors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

MRI in treatment of adult gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Functional magnetic resonance imaging of regional brain activity in patients with intracerebral gliomas: findings and implications for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Results of Re-Irradiation of Primary Intracranial Neoplasms with Three-Dimensional Conformal Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Gamma knife for glioma: selection factors and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14737175.5.4.509

21 January 2018

Identifiers

DOI

10.1586/14737175.5.4.509

1 reference

12 August 2017

1 reference